Virax Biolabs Group Ltd (VRAX) Gross margin 2021–2025
Virax Biolabs Group Ltd (VRAX) gross margin by fiscal year — reported gross profit divided by reported revenue.
-838.2%FY2025 · since FY2021: -7.6% → -838.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -838.2% | -870.6 pp |
| FY2024 | 32.3% | +48.3 pp |
| FY2023 | -15.9% | — |
| FY2021 | -7.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice